Oral care compositions and methods of use
This invention relates to oral care compositions comprising zinc phosphate, a first source of stannous (e.g., stannous fluoride); and a second source of stannous, wherein the second source of stannous comprises stannous pyrophosphate, as well as to methods of using and of making these compositions.
1. An oral care composition comprising:
a zinc source comprising zinc phosphate;
a first source of stannous, wherein the stannous comprises stannous fluoride;
a second source of stannous, wherein the second source of stannous comprises stannous pyrophosphate; and
one or more surfactant, wherein the total amount of the one or more surfactant is from about 0.1 to 3 wt. %, based on the total weight of the oral care composition.
2. The oral care composition of claim 1 , wherein the zinc phosphate is a preformed salt of zinc phosphate.
3. The oral care composition of claim 1 , wherein the zinc phosphate is present in an amount sufficient so that the stannous fluoride dissociates to provide a therapeutically effective amount of stannous ions in aqueous solution.
4. The oral care composition of claim 1 , wherein the amount of zinc phosphate is from 0.05 to 10% by weight, relative to the weight of the oral care composition.
5. The composition of claim 1 , wherein the first stannous ion source further comprises a stannous halides selected from stannous chloride dihydrate, stannous pyrophosphate, organic stannous carboxylate salts such as stannous formate, acetate, gluconate, lactate, tartrate, oxalate, malonate and citrate, stannous ethylene glyoxide, and a mixture thereof.
6. The composition of claim 1 , wherein the first stannous ion source is stannous fluoride.
7. The composition of claim 1 , wherein the composition comprises an effective amount of one or more alkali phosphate salts selected from sodium phosphate dibasic, potassium phosphate dibasic, dicalcium phosphate dihydrate, calcium pyrophosphate, tetrasodium pyrophosphate, tetrapotassium pyrophosphate, sodium tripolyphosphate, disodium hydrogen orthophosphate, monosodium phosphate, pentapotassium triphosphate, and a mixture of two or more thereof.
8. The composition of claim 1 , wherein the alkali phosphate salt is tetrapotassium pyrophosphate.
9. The composition of claim 1 , wherein the alkali phosphate salt is sodium tripolyphosphate.
10. The composition of claim 1 , wherein the composition comprises: a thickening agents selected from the group consisting of carboxyvinyl polymers, hydroxyethyl cellulose, sodium carboxymethyl cellulose, sodium carboxymethyl hydroxyethyl cellulose, and a combination of two or more thereof.
11. The composition of claim 1 , wherein the composition comprises:
a. Zinc phosphate about 1.0 wt. %;
b. Stannous pyrophosphate about 0.2 wt. %; and
c. Tetrasodium pyrophosphate about 2.0 wt. %.
12. The composition of claim 1 , wherein the composition comprises:
a. Zinc phosphate about 1.0 wt. %;
b. Stannous pyrophosphate about 0.3 wt. %; and
c. Tetrasodium pyrophosphate about 2.0 wt. %.
13. The composition of claim 1 , wherein the composition comprises:
a. Zinc phosphate about 1.7 wt. %;
b. Stannous pyrophosphate about 1.0 wt. %; and
c. Tetrasodium pyrophosphate about 2.0 wt. %.
14. The composition of claim 1 , further comprising a citrate buffer system, wherein the buffer system comprises tri-sodium citrate and citric acid.
15. A method to improve oral health comprising applying an effective amount of the oral composition of claim 1 , wherein the oral care composition is applied to the oral cavity of a subject in need thereof.